The global carrier screening market was valued at USD 2.00 Billion in 2024 and is expected to grow at a CAGR of 12.40% from 2025 to 2034, reaching USD 6.44 Billion by 2034.
Carrier screening helps identify genetic mutations in prospective parents that could lead to inherited disorders in their offspring. The growth in this market is fueled by:
-
Increasing awareness about genetic disorders and prenatal health.
-
Rising adoption of next-generation sequencing technologies in healthcare.
-
Growth in fertility treatments and assisted reproductive technologies (ART).
-
Government initiatives supporting genetic testing and prenatal screening programs.
-
Technological advancements enabling faster and more accurate detection of carriers.
Market Breakup by Type
The carrier screening market is segmented based on the type of test:
-
Expanded Carrier Screening (ECS) – Comprehensive testing for multiple genetic disorders in a single panel.
-
Targeted Disease Carrier Screening – Focused on screening for specific, high-risk genetic conditions.
-
Customized Panel Testing – Personalized screening based on family history or ethnicity.
-
Predesigned Panel Testing – Standardized panels for common genetic conditions.
Market Breakup by Product and Service
The market is driven by both products and services:
-
Product – Includes testing kits, reagents, and consumables used in carrier screening.
-
Service – Laboratory-based screening, counseling, and reporting services offered by specialized genetic testing providers.
Market Breakup by Technology
Carrier screening relies on advanced molecular technologies for accurate detection:
-
DNA Sequencing – Next-generation sequencing (NGS) and whole-exome sequencing for comprehensive analysis.
-
Polymerase Chain Reaction (PCR) – Amplification of genetic material for targeted mutation detection.
-
Microarrays – High-throughput technology for detecting multiple genetic variants simultaneously.
-
Others – Emerging technologies such as CRISPR-based assays and digital PCR.
Market Breakup by Medical Condition
Carrier screening addresses multiple medical conditions, including:
-
Hematologic Conditions – Such as sickle cell anemia and thalassemia.
-
Pulmonary Conditions – For example, cystic fibrosis.
-
Neurological Conditions – Including spinal muscular atrophy and Tay-Sachs disease.
-
Others – Rare genetic disorders affecting metabolism, vision, and hearing.
Market Breakup by End User
Key end users adopting carrier screening solutions include:
-
Hospitals and Clinics – Offering prenatal and genetic counseling services.
-
Laboratories – Conducting high-throughput genetic tests.
-
Fertility Clinics – Integrating carrier screening with ART and IVF treatments.
-
Others – Research institutes, academic centers, and specialized diagnostic centers.
Market Breakup by Region
Regional dynamics play a crucial role in market growth:
-
North America – Dominates due to well-established genetic testing infrastructure, high awareness, and supportive regulations.
-
Europe – Growth driven by increasing government support for prenatal screening and high adoption of ECS.
-
Asia Pacific – Rapid expansion due to rising healthcare investments, improving genetic testing facilities, and growing fertility treatments.
-
Latin America – Moderate growth, fueled by increasing healthcare awareness and urbanization.
-
Middle East and Africa – Emerging market with opportunities from rising demand for prenatal testing and early detection of genetic disorders.
Companies Covered
The carrier screening market is highly competitive, with key players focusing on innovation, partnerships, and geographic expansion:
-
Thermo Fisher Scientific – Provides advanced genomic tools and reagents for genetic testing.
-
Invitae Corporation – Offers a broad range of genetic testing services including ECS.
-
Fulgent Genetics – Specializes in comprehensive carrier and hereditary disease screening.
-
Otogenetics – Focused on genetic diagnostic solutions.
-
OPKO Health Inc. – Offers molecular diagnostics including carrier screening solutions.
-
Quest Diagnostics Clinical Laboratories, Inc. – Provides clinical genetic testing services worldwide.
-
Myriad Genetics, Inc. – Pioneer in genetic screening and diagnostics.
-
Natera, Inc. – Known for non-invasive prenatal testing (NIPT) and ECS.
-
Laboratory Corporation of America® Holdings – Comprehensive lab services including carrier screening.
-
Illumina, Inc. – Leading provider of NGS technologies for genetic analysis.
-
MedGenome – Offers sequencing and genetic testing services.
-
CENTOGENE N.V. – Specialized in rare disease diagnostics and carrier testing.
Key Market Trends
-
Rising adoption of next-generation sequencing (NGS) for high-throughput, accurate screening.
-
Integration of AI and bioinformatics to analyze large genetic datasets.
-
Increasing prenatal and preconception screening programs in developed countries.
-
Expansion of direct-to-consumer (DTC) genetic testing services for carrier detection.
-
Collaborations between laboratories and fertility clinics to provide end-to-end solutions.
Find More Reports
Geriatric Care Services Market
Interstitial Cystitis Drugs Market
Nuclear Imaging Equipment Market
Aesthetic Lasers and Energy Devices Market
About Us:
Expert Market Research is a leading market research firm delivering data-driven insights to the pharmaceutical, biotechnology, and medical device industries. Our comprehensive research solutions include market research reports, providing in-depth analysis of industry trends and competitive landscapes; drug pipeline reports, tracking drug development progress, clinical trials, and regulatory approvals; epidemiology reports, offering detailed disease prevalence and patient population studies; and patent reports, assessing intellectual property landscapes and innovation trends, among others.
Leveraging proprietary data, advanced analytics, and expert methodologies, we help businesses navigate complex markets, optimize strategies, and drive innovation. We empower clients with actionable intelligence, enabling them to make informed decisions and stay ahead in the rapidly evolving healthcare sector.
Media Contact:
Company Name: Claight Corporation
Contact Person: Roshan Kumar, Digital Marketing
Email: [email protected]
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com
You must be logged in to post a comment.